2023
Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale
Lansky A, McEntegart M. Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale. Cardiovascular Revascularization Medicine 2023, 53: s14. DOI: 10.1016/j.carrev.2023.05.029.Peer-Reviewed Original ResearchCRT-101.06 Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale
Lansky A, McEntegart M. CRT-101.06 Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale. JACC Cardiovascular Interventions 2023, 16: s4. DOI: 10.1016/j.jcin.2023.01.031.Peer-Reviewed Original Research
2022
TCT-207 Intravascular Lithotripsy for Calcified Peripheral Artery Disease (PAD) in Female vs Male Patients: Sex-Specific Analysis From the Disrupt PAD III Observational Study
Nagpal S, McGinigle K, Mangalmurti S, Adams G, Shammas N, Soukas P, Bertolet B, Lansky A. TCT-207 Intravascular Lithotripsy for Calcified Peripheral Artery Disease (PAD) in Female vs Male Patients: Sex-Specific Analysis From the Disrupt PAD III Observational Study. Journal Of The American College Of Cardiology 2022, 80: b83-b84. DOI: 10.1016/j.jacc.2022.08.244.Peer-Reviewed Original ResearchCurrent Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure
Ahmad Y, Lansky AJ, Velazquez EJ. Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure. JAMA Cardiology 2022, 7: 577-578. PMID: 35476046, DOI: 10.1001/jamacardio.2022.0659.Peer-Reviewed Original ResearchChapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease
Binyamin G, Gaston S, Konstantino E, Konstantino M, Lansky A. Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease. 2022, 673-688. DOI: 10.1016/b978-0-12-821451-0.00006-9.Peer-Reviewed Original ResearchPeripheral arterial diseaseAtherosclerotic peripheral arterial diseaseArterial diseaseBalloon angioplastyRevascularization strategyImpaired perfusionClinical syndromeBalloon catheterInvasive treatmentAngioplastyAngioplasty devicesDiseaseClinical applicationStentingPatientsCatheterSyndromePerfusionMainstay
2021
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
Vrachatis DA, Papathanasiou KA, Giotaki SG, Raisakis K, Kossyvakis C, Kaoukis A, Kolokathis F, Deftereos G, Iliodromitis KE, Avramides D, Bogossian H, Siasos G, Giannopoulos G, Reimers B, Lansky A, Tardif JC, Deftereos S. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine. Journal Of Clinical Medicine 2021, 10: 5128. PMID: 34768648, PMCID: PMC8584586, DOI: 10.3390/jcm10215128.Peer-Reviewed Original ResearchImmunologic dysregulationPathophysiologic backgroundImmunomodulating capacitySARS-CoV-2 infectionEffective therapeutic modalityCOVID-19 infectionDate systematic reviewSARS-CoV-2Thrombotic pathwaysClinical featuresDisease complicationsImmunomodulating roleTherapeutic modalitiesPathophysiologic importanceSystematic reviewHealth systemNovel diseaseHypercoagulabilityComplicationsCOVID-19InfectionDysregulationPivotal roleSignificant numberDiseaseRepurposing colchicine’s journey in view of drug-to-drug interactions. A review
Vrachatis DA, Papathanasiou KA, Giotaki SG, Iliodromitis KE, Papaioannou TG, Stefanini GG, Cleman M, Siasos G, Reimers B, Lansky A, Tardif JC, Deftereos SG, Giannopoulos G. Repurposing colchicine’s journey in view of drug-to-drug interactions. A review. Toxicology Reports 2021, 8: 1389-1393. PMID: 34285885, PMCID: PMC8280530, DOI: 10.1016/j.toxrep.2021.07.009.Peer-Reviewed Original Research
2020
QUANTITATIVE FLOW RATIO ACCORDING TO THREE-DIMENSIONAL QUANTITATIVE CORONARY ANGIOGRAPHY DEFINED SEVERITY OF STENOSIS IN A COHORT OF WOMEN WITH STABLE CORONARY ARTERY DISEASE
Gitto M, Saito Y, Schneider M, Papoutsidakis N, Ardito S, McCarthy M, Cristea E, Lansky A, Altin S. QUANTITATIVE FLOW RATIO ACCORDING TO THREE-DIMENSIONAL QUANTITATIVE CORONARY ANGIOGRAPHY DEFINED SEVERITY OF STENOSIS IN A COHORT OF WOMEN WITH STABLE CORONARY ARTERY DISEASE. Journal Of The American College Of Cardiology 2020, 75: 177. DOI: 10.1016/s0735-1097(20)30804-4.Peer-Reviewed Original ResearchDISCREPANCY BETWEEN VISUALLY ASSESSED AND QUANTITATIVE CORONARY ANGIOGRAPHY DERIVED DIAMETER STENOSIS IN A COHORT OF WOMEN WITH STABLE CORONARY ARTERY DISEASE
Gitto M, Saito Y, Schneider M, Papoutsidakis N, Ardito S, McCarthy M, Cristea E, Lansky A, Altin S. DISCREPANCY BETWEEN VISUALLY ASSESSED AND QUANTITATIVE CORONARY ANGIOGRAPHY DERIVED DIAMETER STENOSIS IN A COHORT OF WOMEN WITH STABLE CORONARY ARTERY DISEASE. Journal Of The American College Of Cardiology 2020, 75: 178. DOI: 10.1016/s0735-1097(20)30805-6.Peer-Reviewed Original Research
2019
TCT-237 Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
Shah T, Gul B, Head S, Abbott J, Chieffo A, Baumbach A, Hu X, Li F, Brackett A, Gesick C, Bisarya P, Mehran R, Grines C, Geirsson A, Mehilli J, Lansky A. TCT-237 Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials. Journal Of The American College Of Cardiology 2019, 74: b236. DOI: 10.1016/j.jacc.2019.08.303.Peer-Reviewed Original Research
2017
TCT-762 The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients with Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study
Bouras G, Sullivan T, Zeller T, Nakamura M, Cristea E, Xin Z, Lansky A. TCT-762 The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients with Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study. Journal Of The American College Of Cardiology 2017, 70: b322. DOI: 10.1016/j.jacc.2017.09.1001.Peer-Reviewed Original Research
2016
Controversies in the Treatment of Women with ST-Segment Elevation Myocardial Infarction
Ng VG, Lansky AJ. Controversies in the Treatment of Women with ST-Segment Elevation Myocardial Infarction. Interventional Cardiology Clinics 2016, 5: 523-532. PMID: 28582000, DOI: 10.1016/j.iccl.2016.06.014.Peer-Reviewed Original ResearchConceptsST-segment elevation myocardial infarctionElevation myocardial infarctionMyocardial infarctionWorse outcomesOutcomes of womenCoronary artery diseaseCause of deathTreatment of womenReperfusion therapyAggressive treatmentArtery diseaseLate therapyTreatment optionsDisease presentationOutcome disparitiesPlaque developmentInfarctionTherapyWomenYoung menOutcomesMenTreatmentPathophysiologyDisease
2014
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
Litsky J, Chanda A, Stilp E, Lansky A, Mena C. Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent. Medical Devices Evidence And Research 2014, Volume 7: 149-156. PMID: 24920940, PMCID: PMC4045256, DOI: 10.2147/mder.s45472.Peer-Reviewed Original ResearchSuperficial femoral arteryPeripheral arterial diseaseArterial diseaseSymptomatic peripheral arterial diseasePercutaneous transluminal balloon angioplastyPreferred initial therapyTransluminal balloon angioplastySelf-expanding nitinol stentsInitial therapyObstructive lesionsSFA diseaseEndovascular managementObstructive diseaseEndovascular treatmentAdequate therapyBalloon angioplastySFA stenosisFemoral arteryDurable resultsClinical practiceLong occlusionsDiseaseNitinol stentsStentsBiomechanical forces
2013
Pre-hypertension: another 'pseudodisease’?
Meier P, Messerli FH, Baumbach A, Lansky AJ. Pre-hypertension: another 'pseudodisease’? BMC Medicine 2013, 11: 211. PMID: 24229371, PMCID: PMC3848832, DOI: 10.1186/1741-7015-11-211.Peer-Reviewed Original ResearchConceptsBlood pressureCardiovascular riskRisk factorsCommon cardiovascular risk factorsCardiovascular risk factorsEnd-organ damageIndependent risk factorRisk markersHealthy peopleHypertensionBMC MedicineMmHgPseudodiseaseExpert CommitteeSignificant proportionSignificant markersRiskMarkersSystolicPatientsDiseaseDiagnosing and Characterizing Coronary Artery Disease in Women: Developments in Noninvasive and Invasive Imaging Techniques
Ng VG, Meller S, Shetty S, Lansky AJ. Diagnosing and Characterizing Coronary Artery Disease in Women: Developments in Noninvasive and Invasive Imaging Techniques. Journal Of Cardiovascular Translational Research 2013, 6: 740-751. PMID: 23918630, DOI: 10.1007/s12265-013-9500-1.Peer-Reviewed Original ResearchThe collateral circulation of the heart
Meier P, Schirmer SH, Lansky AJ, Timmis A, Pitt B, Seiler C. The collateral circulation of the heart. BMC Medicine 2013, 11: 143. PMID: 23735225, PMCID: PMC3689049, DOI: 10.1186/1741-7015-11-143.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseCollateral arteriesArtery diseaseCollateral circulationCoronary arteryOcclusive coronary artery diseaseRelevant protective roleEpicardial coronary arteriesFirst clinical trialIntracoronary pressure measurementsRecent pilot studyExternal counterpulsationEnd arteriesClinical trialsBlood supplyArteryProtective roleGranulocyte colonyAnastomotic vesselsPilot studyGrowth factorGold standardDiseasePressure measurementsVessels
2012
TCT-480 Outcomes in Patients with Non-obstructive Coronary Artery Disease With and Without Cardiac Biomarker Elevations: The ACUITY Trial
Newman J, Dangas G, Brener S, Xu K, Genereux P, Lansky A, Nikolsky E, Mehran R, Stone G. TCT-480 Outcomes in Patients with Non-obstructive Coronary Artery Disease With and Without Cardiac Biomarker Elevations: The ACUITY Trial. Journal Of The American College Of Cardiology 2012, 60: b139. DOI: 10.1016/j.jacc.2012.08.512.Peer-Reviewed Original ResearchInterventions for ST Elevation Myocardial Infarction in Women
Ng VG, Lansky AJ. Interventions for ST Elevation Myocardial Infarction in Women. Interventional Cardiology Clinics 2012, 1: 453-465. PMID: 28581963, DOI: 10.1016/j.iccl.2012.06.004.Peer-Reviewed Original ResearchST-segment elevation myocardial infarctionElevation myocardial infarctionReperfusion therapyMyocardial infarctionST-elevation myocardial infarctionOutcomes of patientsMinority of patientsOutcomes of womenCoronary revascularization techniquesCause of deathRevascularization techniquesSupportive careTreatment optionsCardiovascular diseaseEquivalent outcomesTherapyWomenMultiple studiesOutcomesInfarctionPatientsMenThrombolyticsDiseaseTrialsAn intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries
Golinvaux N, Maehara A, Mintz GS, Lansky AJ, McPherson J, Farhat N, Marso S, de Bruyne B, Serruys PW, Templin B, Cheong WF, Aaskar R, Fahy M, Mehran R, Leon M, Stone GW. An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries. American Heart Journal 2012, 163: 624-631. PMID: 22520529, DOI: 10.1016/j.ahj.2011.07.031.Peer-Reviewed Original ResearchConceptsRight coronary arteryCoronary arteryPlaque burdenDistal segmentsDistal LADDistal right coronary arteryAtherosclerotic plaque distributionAnterior descending (LAD) arteryDistal coronary arteriesProximal coronary arteriesDiseased coronary arteriesExternal elastic membraneProximal cross sectionsArtery plaquesIntravascular ultrasound dataPlaque distributionProximal vesselsMid segmentsIntravascular ultrasoundMedian percentageArteryProximal segmentSignificant diseaseLADDiseaseWhole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial
Rosenberg S, Elashoff MR, Lieu HD, Brown BO, Kraus WE, Schwartz RS, Voros S, Ellis SG, Waksman R, McPherson JA, Lansky AJ, Topol EJ, for the PREDICT Investigators. Whole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial. Journal Of Cardiovascular Translational Research 2012, 5: 366-374. PMID: 22396313, PMCID: PMC3349850, DOI: 10.1007/s12265-012-9353-z.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryCoronary AngiographyCoronary Artery BypassCoronary Artery DiseaseFemaleGene Expression RegulationGenetic Predisposition to DiseaseGenetic TestingHumansIschemic Attack, TransientLogistic ModelsMaleMiddle AgedMyocardial InfarctionOdds RatioPhenotypePredictive Value of TestsPrognosisProspective StudiesReproducibility of ResultsRisk AssessmentRisk FactorsStrokeTime FactorsUnited StatesConceptsMajor adverse cardiovascular eventsCoronary artery diseaseObstructive coronary artery diseaseGene expression scoreAdverse cardiovascular eventsCardiovascular eventsArtery diseaseClinical risk scoreGroup of patientsNegative predictive valueGene expression testingNondiabetic patientsPREDICT trialAngiography patientsGES groupPREDICT studyRisk scorePatientsPredictive valueExpression scoreRevascularizationEvent ratesDiseaseMonthsExpression testing